Rahul Gosain, MD, of the Oncology Brothers, talks with Marleen Kok, MD, PhD, about how lobular carcinoma — which comprises 10-15% of all invasive breast cancers — differs from ductal carcinoma.
Estimated Read Time:
1 minute
SABCS Snippets: Lobular Breast Cancer
Share
Recent Posts
-
December 15, 2025
-
December 15, 2025
-
FDA session offers closer look at approval process for HR-positive metastatic breast cancer therapies
December 15, 2025 -
December 15, 2025
